DNA Capital, a Venture Fund based in São Paulo, Brazil, was founded in 2013. Specializing in multi-stage investments in the healthcare sector, their fund stages include Seed, Series A, Series B, Series C, and Series D. With a focus on Healthcare, Medical Device, BioTech, and Life Science industries, DNA Capital has invested in 28 companies and celebrated 2 successful exits. The fund is led by Partner Chris Hill, who can be reached at chill@dnacapital.com. Portfolio companies under DNA Capital's wing include Nice Healthcare and Spotlight Therapeutics. For more information, visit their website at www.dnacapital.com.